Arvinas, Inc. (ARVN)
NASDAQ: ARVN · Real-Time Price · USD
7.40
-0.23 (-3.01%)
May 6, 2025, 9:50 AM EDT - Market open
Arvinas Employees
Arvinas had 430 employees as of December 31, 2024. The number of employees decreased by 15 or -3.37% compared to the previous year.
Employees
430
Change (1Y)
-15
Growth (1Y)
-3.37%
Revenue / Employee
$992,791
Profits / Employee
-$108,372
Market Cap
540.14M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 94,300 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
| AbbVie | 55,000 |
ARVN News
- 23 hours ago - Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Arvinas, Inc. (ARVN) And Encourages Stockholders to Reach Out - Accesswire
- 1 day ago - Arvinas: Yet Another Biotech Trading Below Net Cash, But It's Only A Mild Bull Case - Seeking Alpha
- 1 day ago - Bronstein, Gewirtz & Grossman, LLC Is Investigating Arvinas, Inc. (ARVN) And Encourages Stockholders to Connect - Accesswire
- 3 days ago - Arvinas, Inc. (ARVN) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation - Accesswire
- 4 days ago - Arvinas, Inc. (ARVN) Investors Who Have Lost Money Should Contact Block & Leviton to Find Out How They Might Recover Money Through The Firm's Investigation - Accesswire
- 4 days ago - Arvinas, Inc. (ARVN) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 5 days ago - Arvinas Reports First Quarter 2025 Financial Results and Provides Corporate Update - GlobeNewsWire
- 8 days ago - Arvinas to Report First Quarter 2025 Financial Results on Thursday, May 1, 2025 - GlobeNewsWire